Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors

Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors

US Patent 7241777 · Granted Jul 10, 2007

Estimated economic value: $84,590,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Spiro bicyclic inhibitors of menin-MLL interaction2024
Bi-heteroaryl substitute 1,4-benzodiazepines and uses thereof for the treatment 2023
Azepane inhibitors of menin-MLL interaction2022
Exo-aza spiro inhibitors of menin-MLL interaction2022
(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxalin2022
(R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxalin2022
Spiro bicyclic inhibitors of menin-MLL interaction2022
Compounds2021
Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors2021
Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors2021
Cosmetic compositions and method of treating the skin2021
Fused bicyclic inhibitors of menin-MLL interaction2021